Tutorials › Pharmacokinetic-Pharmacodynamic (PK/PD) Modeling › Physiological Scaling of Organ Blood Flow

Preclinical to Clinical Translation · Tutorial 508 of 598

Physiological Scaling of Organ Blood Flow

You will apply the well-stirred liver model to calculate hepatic clearance and extraction, then compare how blood flow and intrinsic capacity shape predictions across species.

Advanced 10 min read

What You'll Learn

  • Calculate hepatic clearance from blood flow and extraction ratio.
  • Derive extraction ratio and clearance from intrinsic clearance and unbound fraction.
  • Identify flow-limited and capacity-limited conditions using the ratio of intrinsic capacity to organ blood flow.
  • Compare hypothetical multispecies predictions without assuming clearance scales directly with blood flow.
  • Recognize consistency checks, model limitations, and when another hepatic disposition model may be useful.

Why Organ Blood Flow Matters

A species difference in hepatic blood flow can change how quickly drug reaches the liver, but flow is not itself hepatic clearance. The fraction extracted on each pass also matters: a liver may remove nearly all drug delivered to it, or only a small fraction. The well-stirred liver model combines these quantities with intrinsic clearance to distinguish these situations and to make explicit when blood flow limits hepatic clearance.

This distinction is useful in preclinical-to-clinical translation because an allometric prediction of total clearance does not, by itself, show whether the liver is flow-limited or capacity-limited. The calculations below isolate hepatic clearance. They do not imply that total systemic clearance equals hepatic clearance if other elimination routes contribute.

Definition: Let \(Q_h\) be hepatic blood flow, in volume per time; \(CL_h\) be hepatic blood clearance, in the same units; \(E_h\) be the hepatic extraction ratio, the fraction of drug entering the liver removed during one passage; \(CL_{int}\) be intrinsic hepatic clearance, defined relative to unbound drug concentration; and \(f_{u,b}\) be the fraction of drug unbound in blood. The well-stirred model is $$ CL_h = \frac{Q_h f_{u,b} CL_{int}}{Q_h + f_{u,b} CL_{int}}, \qquad E_h = \frac{CL_h}{Q_h} = \frac{f_{u,b} CL_{int}}{Q_h + f_{u,b} CL_{int}}. $$ The quantities must use compatible blood-based units and definitions. In particular, a plasma unbound fraction should not be substituted for \(f_{u,b}\) without accounting for the plasma-to-blood relationship.

The model assumes drug is delivered to a well-mixed hepatic compartment, elimination within that compartment is linear over the concentration range considered, and \(Q_h\), \(f_{u,b}\), and \(CL_{int}\) are appropriately represented for the species and conditions of interest. It also treats hepatic elimination as the process governing removal in the model; shunting, substantial extrahepatic elimination, nonlinear binding, or saturable metabolism can make this representation inadequate.

From Intrinsic Capacity to Extraction

The product \(f_{u,b}CL_{int}\) is the effective intrinsic capacity acting on total blood drug concentration. Comparing this product with \(Q_h\) determines the limiting regime. If the product is much larger than flow, extraction approaches one and clearance approaches flow. If it is much smaller than flow, extraction is low and clearance approaches the effective intrinsic capacity.

Key result: Define \(R=f_{u,b}CL_{int}/Q_h\). Then \(E_h=R/(1+R)\) and \(CL_h=Q_hR/(1+R)\). When \(R\) is large, clearance is approximately flow-limited; when \(R\) is small, it is approximately capacity-limited. These are limiting approximations, not separate clearance equations.

The limits follow directly from the model. Dividing the numerator and denominator of \(CL_h\) by \(f_{u,b}CL_{int}\) gives the low-flow-relative-to-capacity limit; dividing by \(Q_h\) gives the high-flow-relative-to-capacity limit:

$$ \frac{f_{u,b}CL_{int}}{Q_h}\to\infty: \quad CL_h=\frac{Q_h}{1+Q_h/(f_{u,b}CL_{int})}\to Q_h, \quad E_h\to 1; \qquad \frac{f_{u,b}CL_{int}}{Q_h}\to 0: \quad CL_h=\frac{f_{u,b}CL_{int}}{1+f_{u,b}CL_{int}/Q_h}\to f_{u,b}CL_{int}, \quad E_h\to 0. $$

A useful rearrangement starts with a measured or specified extraction ratio. Since \(CL_h=Q_hE_h\), substituting into the well-stirred expression and solving for intrinsic clearance gives

$$ CL_{int} = \frac{E_h Q_h}{f_{u,b}(1-E_h)}, \qquad 0\le E_h<1. $$

This inverse calculation becomes sensitive to uncertainty as \(E_h\) approaches one, because \(1-E_h\) is then small. Extraction ratios reported as exactly one therefore cannot be used in this formula to obtain a finite intrinsic clearance.

Worked Example: Inferring Intrinsic Clearance From Extraction

Suppose a hypothetical species has hepatic blood flow \(Q_h=18.0\) L/h, measured extraction ratio \(E_h=0.750\), and blood unbound fraction \(f_{u,b}=0.200\). Calculate hepatic clearance and intrinsic clearance.

First, clearance follows from extraction: $$ CL_h=Q_hE_h=(18.0\ \text{L/h})(0.750)=13.5\ \text{L/h}. $$

Then use the rearranged well-stirred equation: $$ CL_{int} =\frac{E_hQ_h}{f_{u,b}(1-E_h)} =\frac{(0.750)(18.0\ \text{L/h})}{(0.200)(1-0.750)} =\frac{13.5\ \text{L/h}}{0.0500} =270\ \text{L/h}. $$

The effective intrinsic capacity is \(f_{u,b}CL_{int}=(0.200)(270)=54.0\) L/h, three times the hepatic flow. The ratio \(R=54.0/18.0=3.00\) predicts \(E_h=3/(1+3)=0.750\), matching the input. This agreement is also a check on the arithmetic.

Comparing Flow-Limited and Capacity-Limited Predictions

The same blood flow can produce very different clearance when effective intrinsic capacity differs. Conversely, the same effective intrinsic capacity can produce different extraction ratios when flow differs. The following example calculates both regimes at one hypothetical human hepatic blood flow.

Worked Example: Two Regimes at the Same Blood Flow

For a hypothetical adult, take \(Q_h=90.0\) L/h and \(f_{u,b}=0.100\). Compare a drug with \(CL_{int}=9000\) L/h to one with \(CL_{int}=90.0\) L/h. Assume the well-stirred model's linearity and other conditions hold for both.

For the first drug, \(f_{u,b}CL_{int}=(0.100)(9000)=900\) L/h, which is ten times flow. Therefore, $$ CL_h=\frac{(90.0)(900)}{90.0+900} =\frac{81{,}000}{990} =81.82\ \text{L/h}, \qquad E_h=\frac{81.82}{90.0}=0.9091. $$

This is close to the flow limit of 90.0 L/h: about 91% of the drug entering the liver is extracted in the model. Clearance is flow-limited in the approximate sense that a large proportional increase in intrinsic capacity would change clearance relatively little.

For the second drug, \(f_{u,b}CL_{int}=(0.100)(90.0)=9.00\) L/h, one tenth of flow: $$ CL_h=\frac{(90.0)(9.00)}{90.0+9.00} =\frac{810}{99.0} =8.182\ \text{L/h}, \qquad E_h=\frac{8.182}{90.0}=0.09091. $$

This clearance is close to the capacity limit of 9.00 L/h. Only about 9.1% is extracted per passage, so the model predicts that clearance depends much more directly on effective intrinsic capacity than on flow.

Multispecies Calculation: Flow Is Not a Clearance Multiplier

For cross-species prediction, use each species' hepatic flow and its species-specific effective intrinsic capacity. A flow ratio alone predicts a clearance ratio only under additional conditions—for example, if both species are so highly extracted that their clearances are each close to their respective flows. The well-stirred equation makes this dependence calculable rather than assumed.

Worked Example: Rat, Dog, and Human Predictions

Consider hypothetical values for three species. The intrinsic clearances below are already specified on a whole-liver basis; no claim is made that they have been obtained by a particular scaling procedure.

Species\(Q_h\) (L/h)\(f_{u,b}\)\(CL_{int}\) (L/h)
Rat0.2500.10022.5
Dog12.00.100240
Human90.00.10090.0

For the rat, effective intrinsic capacity is \((0.100)(22.5)=2.25\) L/h. Thus $$ CL_h=\frac{(0.250)(2.25)}{0.250+2.25} =\frac{0.5625}{2.50} =0.225\ \text{L/h}, \qquad E_h=\frac{0.225}{0.250}=0.900. $$

For the dog, effective capacity is \((0.100)(240)=24.0\) L/h: $$ CL_h=\frac{(12.0)(24.0)}{12.0+24.0} =\frac{288}{36.0} =8.00\ \text{L/h}, \qquad E_h=\frac{8.00}{12.0}=0.667. $$

For the human, effective capacity is \((0.100)(90.0)=9.00\) L/h: $$ CL_h=\frac{(90.0)(9.00)}{90.0+9.00} =\frac{810}{99.0} =8.182\ \text{L/h}, \qquad E_h=\frac{8.182}{90.0}=0.09091. $$

The rat is strongly flow-limited, the dog is intermediate, and the human is capacity-limited. Although human hepatic flow is 360 times rat flow, the predicted human hepatic clearance is only \(8.182/0.225=36.36\) times the rat clearance. The reason is that extraction falls across these hypothetical species as the ratio of effective capacity to flow decreases. This calculation does not establish that these are realistic species values; it demonstrates why blood-flow scaling alone is insufficient.

Scaling Blood Flow and Choosing a Model

Hepatic blood flow may be measured or estimated for the species and physiological state of interest. If only a body-weight relationship is available, it can be used to make an explicit flow prediction, but the resulting \(Q_h\) should not be mistaken for drug clearance. A species-specific physiological estimate is preferable when available, and the flow definition must be consistent with the blood-based clearance and unbound fraction used in the calculation.

The well-stirred model is often useful because it is simple and makes the flow-capacity competition transparent. A common alternative, the parallel-tube model, represents blood moving through tubes with distributed exposure and gives $$ CL_h=Q_h\left[1-\exp\left(-\frac{f_{u,b}CL_{int}}{Q_h}\right)\right]. $$ Both models predict \(CL_h\) approaching \(f_{u,b}CL_{int}\) at low extraction and \(Q_h\) at high extraction. Their intermediate predictions can differ. The choice should follow the intended physiological representation and available evidence, not whichever formula yields a preferred human estimate. Neither equation automatically handles shunting, nonlinear metabolism, or unmodeled routes of elimination.

In practice, inspect whether predicted clearance is between zero and \(Q_h\), whether \(E_h=CL_h/Q_h\) lies between zero and one, and whether the calculated ratio \(f_{u,b}CL_{int}/Q_h\) agrees with the claimed limiting regime. A value \(CL_h>Q_h\) under this model usually signals inconsistent units, incompatible blood and plasma quantities, or an arithmetic or implementation error. Very high extraction estimates also deserve scrutiny: modest uncertainty in \(f_{u,b}\), flow, or extraction can substantially affect an inferred \(CL_{int}\).

Common Pitfalls and Limitations

  • Equating hepatic clearance with hepatic blood flow. This is only an approximation at high extraction. At low extraction, the model instead gives \(CL_h\) close to \(f_{u,b}CL_{int}\).
  • Scaling clearance by the flow ratio without checking extraction. That reasoning is suitable only when both species are near the flow-limited regime. In intermediate or low-extraction regimes, calculate clearance separately using each species' \(Q_h\) and effective capacity.
  • Mixing plasma and blood measures. The flow, clearance, and unbound fraction must refer to compatible matrices. A mismatch can produce a numerically plausible but physiologically inconsistent prediction.
  • Treating the model as a full translation method. The equation does not determine how \(CL_{int}\) changes between species, establish enzyme-specific scaling, or account for nonhepatic elimination. Those inputs require separate evidence.
Key takeaway: Physiological scaling of hepatic clearance requires both flow and extraction capacity. Calculate \(CL_h\) from the well-stirred relationship for each species, then interpret its regime using \(f_{u,b}CL_{int}/Q_h\); do not substitute a blood-flow ratio for the clearance prediction without justification.

Check Your Understanding

Answer each question, then compare with the brief solutions below.

  1. For \(Q_h=40.0\) L/h, \(f_{u,b}CL_{int}=10.0\) L/h, what are \(CL_h\) and \(E_h\)? Which limit is more relevant?
  2. A hypothetical species has \(Q_h=25.0\) L/h and \(E_h=0.400\). What is \(CL_h\)?
  3. If \(f_{u,b}CL_{int}\) is unchanged while \(Q_h\) doubles, does the well-stirred model predict that clearance doubles? Explain using the limiting regimes.
  4. Why is a measured extraction ratio close to one problematic for estimating \(CL_{int}\) from \(E_h\)?
  5. A calculation gives \(CL_h=1.20Q_h\). Name two issues to check before interpreting the result.

Solutions. (1) \(CL_h=(40.0)(10.0)/(40.0+10.0)=8.00\) L/h and \(E_h=8.00/40.0=0.200\). Since capacity is one quarter of flow, the prediction is closer to capacity-limited. (2) \(CL_h=Q_hE_h=(25.0)(0.400)=10.0\) L/h. (3) Not in general. If capacity is much smaller than flow, clearance remains close to \(f_{u,b}CL_{int}\); if capacity greatly exceeds flow, clearance approximately follows the changed flow. (4) The inverse formula divides by \(1-E_h\), which becomes small, amplifying uncertainty; at \(E_h=1\), it does not yield a finite intrinsic clearance. (5) Check arithmetic and units, and check that blood flow, clearance, and unbound fraction use compatible blood-versus-plasma definitions. Under the well-stirred model with nonnegative inputs, hepatic clearance cannot exceed hepatic flow.

Clinical Biostats